Cases 21 - 30 of 93
Technical LED Intellectual Property, LLC v. Lumenty Technologies, Inc.
as 1:2018cv01959
Plaintiff:
Technical LED Intellectual Property, LLC
Defendant:
Lumenty Technologies, Inc.
Cause Of Action: 35 U.S.C. § 1
Bayer Intellectual Property GMBH et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2018cv01926
Defendant:
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Plaintiff:
Bayer Intellectual Property GMBH, Bayer AG and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. Torrent Pharmaceuticals, Limited et al
as 1:2017cv01163
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Torrent Pharmaceuticals, Limited and Torrent Pharma Inc.
Counter_claimant:
Torrent Pharmaceuticals, Limited and Torrent Pharma Inc.
Counter_defendant:
Bayer AG , Bayer Intellectual Property GmbH and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. Breckenridge Pharmaceutical, Inc.
as 1:2017cv01129
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Breckenridge Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Technical LED Intellectual Property, LLC v. Osram Sylvania Inc.
as 1:2017cv01118
Plaintiff:
Technical LED Intellectual Property, LLC
Defendant:
Osram Sylvania Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. Lupin Limited et al
as 1:2017cv01047
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Counter_claimant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Counter_defendant:
Bayer AG , Bayer Intellectual Property GmbH and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer AG et al v. Mayne Pharma LLC
as 1:2017cv01037
Plaintiff:
Bayer AG , Bayer Intellectual Property GmbH and Bayer HealthCare Pharmaceuticals Inc.
Defendant:
Mayne Pharma LLC
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GMBH et al v. InvaGen Pharmaceuticals, Inc.
as 1:2017cv00812
Plaintiff:
Bayer Intellectual Property GMBH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
InvaGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. Alembic Pharmaceuticals Limited et al
as 1:2017cv00675
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. Sigmapharm Laboratories, LLC
as 1:2017cv00648
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Sigmapharm Laboratories, LLC
Counter_claimant:
Sigmapharm Laboratories, LLC
Counter_defendant:
Bayer AG , Bayer Intellectual Property GmbH and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
